Your browser doesn't support javascript.
loading
A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects.
Ng, Matthew; Chen, Sylvia; Ong, Whee Sze; Balachander, Akhila; Seet, Amanda; Yeong, Joe; Sutiman, Natalia; Lim, Tony Kiat Hon; Lee, Bernett; Guo, Yu Amanda; Leong, Wai Fook; Lee, Sze Sing; Lam, Justina; Choo, Su Pin; Skanderup, Anders Jacobsen; Biswas, Subhra Kumar; Tai, David; Chowbay, Balram.
Afiliación
  • Ng M; Division of Medical Oncology, Department of Gastrointestinal and Neurology, National Cancer Centre Singapore, Singapore, Singapore.
  • Chen S; Laboratory of Clinical Pharmacology, Division of Cellular & Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Ong WS; Division of Clinical Trials & Epidemiology Sciences, National Cancer Centre Singapore, Singapore, Singapore.
  • Balachander A; Singapore Immunology Network, Agency for Science, Technology & Research (A*STAR), Singapore, Singapore.
  • Seet A; Division of Medical Oncology, Department of Gastrointestinal and Neurology, National Cancer Centre Singapore, Singapore, Singapore.
  • Yeong J; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
  • Sutiman N; Laboratory of Clinical Pharmacology, Division of Cellular & Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Lim TKH; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
  • Lee B; Singapore Immunology Network, Agency for Science, Technology & Research (A*STAR), Singapore, Singapore.
  • Guo YA; Computational and Systems Biology, Genome Institute of Singapore (GIS), A*STAR, Singapore, Singapore.
  • Leong WF; Singapore Immunology Network, Agency for Science, Technology & Research (A*STAR), Singapore, Singapore.
  • Lee SS; Laboratory of Clinical Pharmacology, Division of Cellular & Molecular Research, National Cancer Centre Singapore, Singapore, Singapore.
  • Lam J; Division of Medical Oncology, Department of Gastrointestinal and Neurology, National Cancer Centre Singapore, Singapore, Singapore.
  • Choo SP; Division of Medical Oncology, Department of Gastrointestinal and Neurology, National Cancer Centre Singapore, Singapore, Singapore.
  • Skanderup AJ; Curie Oncology, Singapore, Singapore.
  • Biswas SK; Computational and Systems Biology, Genome Institute of Singapore (GIS), A*STAR, Singapore, Singapore.
  • Tai D; Singapore Immunology Network, Agency for Science, Technology & Research (A*STAR), Singapore, Singapore.
  • Chowbay B; Division of Medical Oncology, Department of Gastrointestinal and Neurology, National Cancer Centre Singapore, Singapore, Singapore.
Int J Cancer ; 151(3): 435-449, 2022 08 01.
Article en En | MEDLINE | ID: mdl-35415893
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article